Most-Favored-Nation Pricing

Most-Favored-Nation Pricing is a policy that requires the U.S. government to pay the same price for a drug as the lowest price paid by any other developed country. It is used to reduce prescription drug costs for American patients.

Why it’s in the news: It is in the news because the Trump administration announced deals with pharmaceutical companies like Regeneron to implement this pricing model for specific drugs.

Latest on Most-Favored-Nation Pricing

• Fact Sheet President Donald J Trump Announces Deal With Regeneron To Bring Most Favored Na
• Fact Sheet President Donald J Trump Announces Second Deal To Bring Most Favored Nation Pri

Connections

5 entities linked to Most-Favored-Nation Pricing across the news graph.